[Peptide growth factors in the prostate]
- PMID: 7507232
[Peptide growth factors in the prostate]
Abstract
Growth and development of the prostate depend on androgen action and other factors. Androgens act directly by specific nuclear receptors and induce or control many effects mediated by peptide growth factors on both epithelial and stromal cells. The major important peptide growth factors detected in the prostate are Fibroblast Growth Factors, Transforming Growth Factors, and Epidermal Growth Factor. These factors are not prostate specific. They are produced by epithelial or stromal cells and regulate the growth of these two cell compartments through autocrine or paracrine pathways. Overproduction of these factors or modification in affinity or number of cell receptors may participate in the two main prostatic pathologies: benign hyperplasia or adenocarcinoma. Recently, other factors have been evidenced in the prostate: Interleukine 6, Nerve Growth Factor or Insulin-like Growth factors. The study of the localization and the effects of these factors may be crucial to understand the prostatic development and diseases and may suggest new targets for therapy.
Similar articles
-
Regulation of prostatic growth and function by peptide growth factors.Prostate. 1996 Jun;28(6):392-405. doi: 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO;2-C. Prostate. 1996. PMID: 8650077 Review.
-
Polypeptide modulators of prostatic growth and development.Cancer Surv. 1991;11:123-46. Cancer Surv. 1991. PMID: 1726787 Review.
-
[Role of growth factors in the etiopathogenesis of benign prostatic hyperplasia].Actas Urol Esp. 1994 May;18 Suppl:359-64. Actas Urol Esp. 1994. PMID: 7521109 Review. Spanish.
-
Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.Cytokine. 1999 Sep;11(9):722-7. doi: 10.1006/cyto.1998.0443. Cytokine. 1999. PMID: 10479409
-
Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy.J Urol. 1995 Apr;153(4):1085-96. J Urol. 1995. PMID: 7532724 Review. No abstract available.